Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The company showcased three core programs developed through this platform
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
